---
title: "BeOne Medicines Ltd (6160) Gets a Buy from Daiwa"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/305090273.md"
description: "Daiwa analyst maintained a Buy rating on BeOne Medicines Ltd on November 9 and set a price target of HK$286.00.Currently, the analyst consensus on BeOne Medicines Ltd is a Strong Buy with an average price target of HK$344.56."
datetime: "2026-11-11T01:05:48.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/305090273.md)
  - [en](https://longbridge.com/en/news/305090273.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/305090273.md)
generator: "portal-rs"
---

# BeOne Medicines Ltd (6160) Gets a Buy from Daiwa

Daiwa analyst maintained a Buy rating on BeOne Medicines Ltd on November 9 and set a price target of HK$286.00.

Currently, the analyst consensus on BeOne Medicines Ltd is a Strong Buy with an average price target of HK$344.56.

### Related Stocks

- [ONC.US](https://longbridge.com/en/quote/ONC.US.md)
- [06160.HK](https://longbridge.com/en/quote/06160.HK.md)
- [688235.CN](https://longbridge.com/en/quote/688235.CN.md)

## Related News & Research

- [BeOne Medicines: Five solid-tumor programs advance as strong cash flow funds continued pipeline investment](https://longbridge.com/en/news/305810947.md)
- [BeOne commits $3M to expand CLL Society patient education pact](https://longbridge.com/en/news/305853990.md)
- [BeOne Medicines (ONC) Priority Review And Earnings Put Valuation Back In Focus](https://longbridge.com/en/news/304861942.md)
- [Why BeOne Medicines Stock Is In Focus After Earnings Beat And Raised Guidance](https://longbridge.com/en/news/304730912.md)
- [BeOne stock breaks out with visions of 177% earnings growth. This telltale clue bodes well.](https://longbridge.com/en/news/302773305.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**